Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
AMAmgen Inc. logo

Amgen Inc. (AMGN)

NASDAQ Global Select · Currency in USD
$439.26 ▼ -8.02 (-1.79%)
At close: Oct 23, 4:00 PM ET. Market closed.
$441.99 ▲ +2.73 (+0.62%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$447.28
Open
$443.44
Day's Range
$439.08 – $444.59
52 Week Range
$288.00 – $450.98
Volume
2,074,548
Avg. Volume
2,749,600
Market Cap
$237.48B
Beta (5Y Monthly)
0.41
PE Ratio (TTM)
27.08
EPS (TTM)
$16.19
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
$10.08 (2.29%)
Ex-Dividend Date
Aug 21, 2026
1y Target Est
$403.79

Profile: Amgen Inc.

Sector
Healthcare
Industry
Drug Manufacturers - General
Full-time employees
31,500
CEO
Robert A. Bradway
Website
amgen.com

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate $5.79 · Revenue est. $10.08B
DateEst.Actual
Aug 4, 2026$5.62$6.29Beat
Apr 30, 2026$4.77$5.15Beat
Feb 3, 2026$4.73$5.29Beat
Nov 4, 2025$5.02$5.64Beat
Aug 5, 2025$5.28$6.02Beat
May 1, 2025$4.27$4.90Beat

Analyst view

Consensus price target
$403.79 ▼ -8.1%
Range $230.00 – $500.00
Rating: Buy
Buy 54% · Hold 39% · Sell 7%

Get free alerts on AMGN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.